CEO SUMMARY: Hologic’s acquisition by private equity firms Blackstone and TPG marks one of the year’s largest in vitro diagnostics transactions and a clear vote of confidence in the sector’s resilience. Industry analyst Bruce Carlson unpacks what the buyout reveals about valuation trends, private equity’s growing role, and why IVD remains “a gateway industry” for […]
What Private Equity Sees in Diagnostics
An examination of the $18B Hologic acquisition shows an appetite for lab testing products and data
- By Scott Wallask
- > From the Volume XXXII, No. 16 - November 17, 2025 Issue
- Tags: BD, Becton Dickinson and Company, Blackstone, Bruce Carlson, Carlyle Group, Eye on IVD, Hologic, in vitro diagnostics, in vivo imaging, IVD, Johnson & Johnson, molecular testing, Nova Biomedical, Ortho Clinical Diagnostics, Private equity, Siemens, TPG, Waters Corporation, women’s health diagnostics
